Results 151 to 160 of about 38,268 (270)

1508 Analyzing the genomic, transcriptomic and immune landscapes associated with surface somatostatin receptor 2 (SSTR2) gene expression in nasopharyngeal carcinoma (NPC) [PDF]

, 2023
Dara Bracken‐Clarke, Harris Benjamin Krause, Nishant Gandhi, Phillip Walker, Minh Phan, Rusha Patel, Heloisa P. Soares, Emil Lou, Ari M. Vanderwalde, James L. Gulley, Charalampos S. Floudas   +10 more
openalex   +1 more source

Biomaterial Strategies for Targeted Intracellular Delivery to Phagocytes

Advanced Functional Materials, Volume 36, Issue 1, 2 January 2026.
Phagocytes are essential to a functional immune system, and their behavior defines disease outcomes. Engineered particles offer a strategic opportunity to target phagocytes, harnessing inflammatory modulation in disease. By tuning features like size, shape, and surface, these systems can modulate immune responses and improve targeted treatment for a ...
Kaitlyn E. Woodworth, Neal I. Callaghan, Locke Davenport Huyer   +2 more
wiley   +1 more source

The potential of somatostatin receptor 2 as a novel therapeutic target in salivary gland malignant tumors. [PDF]

J Cancer Res Clin Oncol, 2021
Meirovitz A, Shouchane-Blum K, Maly A, Bersudski E, Hirshoren N, Abrams R, Popovtzer A, Orevi M, Weinberger J.   +8 more
europepmc   +1 more source

Somatostatin 2 Receptors in the Spinal Cord Tonically Restrain Thermogenic, Cardiac and Other Sympathetic Outflows [PDF]

, 2019
Belinda R. Bowman, Phillip Bokiniec, Simon McMullan, Ann K. Goodchild, Peter G.R. Burke   +4 more
openalex   +1 more source

Supplementary Figure Legends 1-2 from Somatostatin Receptor sst2 Decreases Cell Viability and Hormonal Hypersecretion and Reverses Octreotide Resistance of Human Pituitary Adenomas [PDF]

, 2023
Julie Acunzo, Sylvie Thirion, Catherine Roche, Alexandru Saveanu, Ginette Gunz, Anne Laure Germanetti, Bettina Couderc, Richard A. Cohen, Dominique Figarella‐Branger, Henry Dufour, Thierry Brue, A Enjalbert, Anne Barlier   +12 more
openalex   +1 more source

Indications for Surgical Resection in Patients With Neuroendocrine Tumor Liver Metastases: An Intensive Surgical Experience of a High‐Volume Center

Annals of Gastroenterological Surgery, Volume 10, Issue 1, Page 219-228, January 2026.
In patients with NELM, those with < 8 liver metastases and G1/2 tumors are the favorable candidates for liver resection. The important point of this study is that the patients who do not meet the above criteria should be considered for multidisciplinary treatment because of their extremely shorter recurrence‐free period.
Daisuke Asano, Toshitaka Sugawara, Keiichi Akahoshi, Shotaro Gan, Shohei Motohashi, Shuichi Watanabe, Yoshiya Ishikawa, Hiroki Ueda, Atsushi Kudo, Daisuke Ban   +9 more
wiley   +1 more source

Figure S1, Figure S2, Figure S3, Figure S4, Figure S5, Figure S6, Table S1 from Upregulation of Somatostatin Receptor Type 2 Improves ¹⁷⁷Lu-DOTATATE Therapy in Receptor-Deficient Pancreatic Neuroendocrine Tumor Model [PDF]

, 2023
Rupali Sharma, Bhargav Earla, Kwamena E. Baidoo, Martha A. Zeiger, James P. Madigan, Freddy E. Escorcia, Samira M. Sadowski   +6 more
openalex   +1 more source

Molecular Deconvolution of Circulating “Other Cells”: A Reliable Predictive Marker of Therapy Response and Survival in Neuroendocrine Tumor Patients Receiving 177Lu‐DOTATATE PRRT

Cancer Medicine, Volume 15, Issue 1, January 2026.
ABSTRACT Purpose To assess the prognostic impact of pre‐treatment circulating other cells on treatment response and survival in neuroendocrine tumor (NET) patients receiving Peptide Receptor Radionuclide Therapy (PRRT) with 177Lu‐DOTATATE. Methods Healthy donors (HDs, n = 81) and NET patients (n = 137) were analyzed.
Mahesh K. Padwal, Rahul V. Parghane, Sandip Basu, Bhakti Basu   +3 more
wiley   +1 more source

Understanding the influence of lipid bilayers and ligand molecules in determining the conformational dynamics of somatostatin receptor 2. [PDF]

Sci Rep, 2021
Nagarajan SK, Babu S, Kulkarni SA, Vadivelu A, Devaraju P, Sohn H, Madhavan T.   +6 more
europepmc   +1 more source

Advancements in Targeted Radiopharmaceuticals: Innovations in Diagnosis and Therapy for Enhanced Cancer Management

ChemBioChem, Volume 27, Issue 1, January 2026.
Radiopharmaceuticals enable precise cancer diagnosis and targeted therapy by combining radioactive isotopes with carrier molecules. This review summarizes advances from 2014 to 2025, emphasizing probe design, click chemistry, novel targets, and nanodelivery systems.
Mohd Sayeed Shaikh, Rupesh R. Kurhade, Abrar A. M. Siddiqui, Shaikh Shahbaz A. Majeed, Thomas J. Webster, Mohammad Intakhab Alam, Abdul Wasy Zia, Md. Faiyazuddin   +7 more
wiley   +1 more source